With a thirteenth hour trade agreement putting the four-year-long Brexit ordeal in the rearview mirror, the U.K. now has the independence to cut a new path as a regulatory innovator while its scientists...

Emer Cooke has succeeded Guido Rasi as EMA’s executive director, giving the regulatory agency its first new leader since 2011, handing the Irish national the task of navigating the agency through...

The 18 members of the advisory committee that will meet Thursday to discuss FDA’s criteria for emergency use authorization of COVID-19 vaccines bring a variety of expertise and priorities to the table, from statistical chops...

Two weeks after former AstraZeneca CMO Sean Bohen took over as president and CEO, Olema has raised $85 million in a series C round led by Vivo Capital. The San Francisco company’s next financing may well...

Two months after closing a $54 million series B round, breast cancer company Olema has followed up a flurry of executive hires with the addition of former AstraZeneca CMO Sean Bohen as president and CEO. ...

DISEASE CATEGORY: Cancer INDICATION: Brain cancer Inhibiting AFF4 and CDK9, components of the transcription-regulating super elongation complex, could treat diffuse midline glioma. In human diffuse midline glioma cell lines, shRNAs targeting AFF4 or CDK9 or...

In its second major -- and potentially transformational -- deal with a U.S. company, BeiGene has entered a development and commercialization deal with Amgen that adds nearly two dozen compounds to the Chinese biotech’s marketed...